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ScienceDirectFor proteins to become allergenic, they need to acquire
features enabling them to induce B cell activation and isotype
switch to IgE production. Crosslinking of the B-cell receptor
(BCR) is the most efficient way to productively activate B-cells.
The IgE-crosslinking capability of allergens is equally crucial in
the effector phase of immediate type allergy. Antigens, which
acquire enhanced crosslinking capacity by oligomerization,
aggregation, or the expression of repetitive epitopes may
therefore gain allergenic potency. The accumulated evidence
for repetitive epitope display by allergens suggests the
existence of allergen-associated molecular patterns.
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Introduction
The concept of allergen-associated molecular patterns
(AAMPs) was proposed [1] based on the particular features
of immunoglobulin E (IgE) when acting either as B-cell
receptor or bound to high-affinity receptor FceRI, and the
resulting requirements for repetitive epitope display by
allergens achievable by natural or artificial oligomerization.
This review continues with the current models of BCR-
activation and an updated list of allergens expressing AAMPs.
Activation models of resting B-cells
The B-cell receptor
In single mature B-cells, mIgM and mIgD (with the same
specificity) act as B-cell receptors (BCR) in differentwww.sciencedirect.com protein islands [2]. They are co-expressed with the het-
erodimeric signaling subunit of immunoglobulin a (Iga)
and Igb. On the plasma membrane of a resting B-cell,
about 120 000–200 000 BCR copies reside with an inter-
molecular distance of approx. 40 nm [3]. Whether mem-
brane-bound or secreted, immunoglobulins represent
homodimeric molecules of heavy and light chains. They
are therefore equipped with two identical antigen-binding
sites called paratopes, except the IgG4 subclass, which
may be hetero-bivalent [4]. These paratopes have an
average size of 65  35 A˚ [5]. Their binding partners on
the antigens are the epitopes, which measure 600–1000 A˚2,
for example, 774 A˚2 on hen’s egg white lysozyme [6].
Binding of antigen via epitopes to the BCR leads to cellular
activation via Bruton’s tyrosine (Bt) kinases [7], which play
a role in antigen processing and presentation [8], conse-
quently targeting protein into the HLA II compartment for
subsequent T-cell activation [9]. Regarding the mode of
activation of the BCR, different models have been pro-
posed [10]. In the conformation-induced oligomerization
model [11], changes in the mIgM domain closest to the
membrane (Cm4-domain) are prompted when antigen is
bound to monomeric BCR on resting B-cells, leading to the
unleashing of the cytoplasmic domains for signaling.
On the other hand, the dissociation activation model
proposes that in the resting state the BCR exists in an
auto-inhibited oligomeric form, but dissociates upon
binding of a polyvalent antigen [12]. The BCR clusters
on the cell surface seem to segregate into class-specific
islets [12], with an average size of 150 nm for IgM-BCRs
or 240 nm for IgD-BCRs islets [2].
The collision–coupling model was developed based on
the observation that, in the absence of any specific anti-
gen, actin-depolymerizing agents latrunculin A and cyto-
chalasin D could initiate BCR signaling. It suggests that
the resting BCR in a diffusion dynamic status is defined
by the actin cytoskeleton, controlling interaction between
BCR and functional co-elements [13].
In the classical view, binding of at least two individual
BCR by a polyvalent antigen is a precondition for activa-
tion of B-cells, whereas short monomeric soluble antigens
drive them into unresponsiveness [5].
In all the BCR activation models, ‘polyvalent’ implies
that identical epitopes must be presented to the mono-
specific B-cell clone [14]. In an isotype-specific manner,Current Opinion in Immunology 2016, 42:113–118
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(a) IgE-BCRs (yellow men) are floating in the fluidic membrane of a B-
cell (blue ocean), as an allergen source (helicopter) approaches. (b)
The helicopter (allergen source) releases diverse molecules, with or
without allergenic capacity. (c) From left to right: IgE capturing a
monovalent or too small allergen (ball), or IgEs capturing an antigen
with flexible epitope display (flat mattress) do not lead to B-cell
activation (desperate men). In contrast, rigid display of epitopes
(inflated mattress) leads to BCR crosslinking and activation; likewise
complexing of several allergens is able to crosslink IgE-BCR (group in
the back), also leading to activation.
Illustration by Oliver Ottitsch.IgM-BCR is activated by low-valence antigens, setting
the B-cell to a resting state, while IgD-BCR is not
responsive to monovalent antigens; in contrast, a polyva-
lent antigen can stimulate IgM-BCR and IgD-BCR. As
IgD is absent from immature B-cells and most highly
expressed on mature follicular B-cells, it was suggested
that maturation and IgD expression shift the responsive-
ness of conventional B2-cells towards multimeric anti-
gens [15]. Thus, considering the monoclonality of the B-
cell, antigens can achieve BCR activation capacity either
by repetitively displaying identical epitopes or by forming
homo-oligomers. However, in a recent experimental
model, monovalent engagement of an OVA-specific
BCR with a 17mer OVA-peptide was sufficient for B-cell
activation [5], that is, ERK1/2 phosphorylation, BCR
clustering, Ca2+ flux and CD86 expression, while anti-
body production was not assessed. Thus, monomeric
antigens may activate B-cells when exceeding the thresh-
old required for BCR activation [9]. However, dimer-
ization of the 17mer — and only oligomerization of a
shorter 8mer peptide up to hexamers — clearly enhanced
the B-cell stimulatory capacity [5], finally confirming that
increased valency favors B-cell activation. Accordingly,
the monomeric 8mer exhibited a blocking function and
led to unresponsiveness. These results underline that
crosslinking of the BCR via at least dimerization of
antigens is the most efficient way to activate B-cells.
B-cell epitope requirements for IgE synthesis
TI-1 antigens, which induce T-cell independent IgM
responses, are typically polymeric high-molecular weight
antigens like polysaccharide antigens [16], lipopolysac-
charide, or vesicular stomatitis virus antigens (VSV-G).
They represent polyclonal B-cell stimulators, as they are
potent specific crosslinkers of the B-cell receptors. The
distance of 5–10 nm between the VSV-G repetitive epi-
topes in the viral envelope, which lead to TI B-cell
activation [17], is actually in accordance with the classic
definition of the ‘immunon’ [18]. This also implies that if
the spacing of epitopes is too large, this leads to non-
responsiveness rather than activation [19]. The epitopes
therefore have to be presented at an optimal density and
in spacing rigid enough to allow productive receptor
crosslinking (Figure 1). When soluble vesicular stomati-
tis virus glycoprotein (VSV-G) was displayed as highly
repetitive epitopes on the envelope, it could efficiently
evoke IgM-antibody responses in mice. However, B-
cells remained unresponsive when the same antigen
was presented in a low-density manner [17]. Moreover,
in a transgenic mouse model expressing VSV-G, mice
were unresponsive to less organized antigens, including
soluble monomeric protein, and only responded to re-
petitively organized epitopes. Whereas loose antigen
aggregates generated T-cell dependent antibody
responses, a highly ordered viral capsid presentation
produced T-cell independent (TI) antibodies (in agree-
ment with [7]).Current Opinion in Immunology 2016, 42:113–118 www.sciencedirect.com
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Table 1
Allergens reported after 2010 to form dimers or multimers
(continuation of list in [1]).
Allergen (source/identified in) Year of
publication
Reference
Api g 1 (celery) 2010 [41]
Can f 2 (dog dander) 2014 [54]
Can f 4 (dog dander) 2014 [54]




Hev b 2 (latex) 2014 [56]
Hev b 8 (latex) 2010 [41]
Mal d 1 (apple) 2010 [41]
Phl p 6 (grass pollen) 2010 [41]
Black tiger prawn antigens 2014 [40]




Titin (prawn) 2014 [40]
Triose phosphate isomerase TIM (prawn) 2014 [40]Human IgE+ B-cells may be generated from IgM+ cells
through sequential [20] or direct class switching [21] with
or without T-cell help [22]. Moreover, recent work
suggests that IgE can be derived from previously anti-
gen-experienced B cells rather than from naive B cells
[23]. It is likely that several mechanisms of IgE-BCR
activation are at play. Nevertheless, the geometry and
great flexibility of the IgE molecule, exhibiting four
constant domains and a rotation capacity of the Fabs
different from other isotypes, render IgE especially dy-
namic [24]. Conversely, an allergen’s displayed epitopes
may require a particular density to evoke an IgE-B-cell
response. In addition, antibody responses in sensitized
mice could be more efficiently boosted with a dimeric, as
opposed to a monomeric, allergen [25]. Moreover, aggre-
gated protein antigens potently induce immunoglobulin
production if they efficiently crosslink the BCR [7]. This
emphasizes that allergens need to display at least two
identical epitopes to be able to directly activate the
specific B-cells and induce early and rapid IgE-antibody
production even before T-cell help arrives [22]. How-
ever, when IgE is formed it may, via CD23 mediated
uptake, further accelerate T-cell help by IgE-facilitated
antigen presentation by B-cells [26].
Crosslinking — indispensable for the IgE-
mediated effector response
The spacing of IgE epitopes is also pivotal in triggering
the effector phase of type I allergy. IgE resides with high
affinity on FceRI receptors of effector cells like mast cells,
eosinophils, and basophils, as well as on dendritic cells,
where it also supports IgE-facilitated antigen presenta-
tion [26].
The proximity of epitopes on artificial allergens deter-
mines the effector cell response [27]. This is supported
by elegant IgE-crosslinking studies where rigidly
spaced bivalent haptens, molecules with an epitope
spacing from 10–24 A˚ [28,29] to 80–240 A˚ [30], have
shown degranulation efficacy. These studies point to-
wards an optimal distance of 92–102 A˚ between two
IgE molecules for crosslinking at the cellular level, in
other studies expressed as 5–24 nm [31–33], while the
limit for the IgE receptor radius was calculated as 45–
50 A˚ [30].
The efficient crosslinking of effector cells is further
favored by the outstanding affinity of IgE to allergens
in the order of 1010–1011 molar, as shown for major
birch and grass pollen allergens [34]. Although in princi-
ple IgE with any specificity can be captured by the FceRI
receptors, in reality the clonal repertoire in allergic and
asthmatic patients seems to be limited to a few high
affinity clones [35]. While the response in children with
allergic asthma is antigen driven [36], in children with
atopic dermatitis it is rather a clonally restricted super-
antigen-driven response [37].www.sciencedirect.com Therefore, also at the effector cell level the allergen
geometry in combination with the IgE clonality decides
whether IgE crosslinking occurs. Novel platforms
allowing epitope display in liposomes are being devel-




The occurrence of repetitive epitopes on single native
allergen molecules has been reported for latex Hev b 5,
cockroach Bla g 1, tropomyosin from shrimp, house dust
mites and insects, and on high-molecular weight proteins
of wheat [39]. Recently, titin, a heat-stable invertebrate
muscle protein, was identified in Black tiger prawn as an
allergen, comprising 300 tandem repeats of Ig-like and
fibronectin-like units and a native size of around
3000 kDa [40]. Furthermore, most of the other allergens
in prawns, found or described in the same paper, existed
as dimers or oligomers in their native status.
An additional, plausible mode to achieve repeated display
of epitopes is the oligomerization of antigens. In fact,
many allergenic molecules have been reported to occur as
either stable or transient dimers or higher oligomers
through covalent binding or aggregation. In analogy to
pathogen-associated molecular patterns (PAMPs), the
concept of ‘allergen-associated molecular patterns’
(AAMPs) could be useful in the understanding of IgE-
mediated allergies. The list of dimeric or multimeric
allergens has been growing (Table 1). Among the avail-
able 55 crystal structures of allergens, 80% represent
dimers or higher homo-oligomers [41]. Furthermore,
the 10 following lipocalin allergens harbor a dimeric or
tetrameric structure [42]: Rat n 1 from rat urine, Can
f 2 and Can f 4 from dog dander and saliva, Equ c 1 fromCurrent Opinion in Immunology 2016, 42:113–118
116 Allergy and hypersensitivityhorse, Bal g 4 from cockroach, Bos d 2 and Bos d 5 from
bovine secretions and milk, Mus m 1 from mouse dander
and urine, Per a 4 from cockroach, and Arg r 1 from pigeon
tick. It was further suggested that the allergen, even when
occurring in monomeric form, could bind to IgE fixed to
FceRI receptors and thereby prompt a local increase of
allergen concentration, allowing for dimerization and
crosslinking [42].
Especially for small proteins with only few or even a
single immunodominant B-cell epitope, oligomerization
may provide the necessary means for efficient IgE-cross-
linking. Examples where only single dominant epitopes
have been found are the allergens Api m 4 from bee
venom, Amb a 5 from Ambrosia pollen, Der p 1 from
house dust mite and Bet v 1 from birch [1]. Accordingly,
oligomeric allergens triggered the mediator release from
effector cells more efficiently than their monomeric coun-
terparts, for example, Phl p 1 of grass pollen, DNP-
antigen and Bet v 1.
The most striking example, however, is the food allergen
Ara h 1. It achieves its allergenic capacity by dry roasting
[43] which results in stable trimers. Even larger Ara h
1 oligomers are formed by interaction with pro-anthocya-
nidins [44]. The fact that boiling renders hypoallergenic
aggregates, which are morphologically distinct from those
formed by roasting, highlights the importance of food
processing in allergenicity [45].
Recent food technology studies also concentrated on the
process of enzymatic crosslinking of proteins in food, for
example, by the polyphenol oxidase called laccase
[46,47] or tyrosinases from fungi [48], which are used
in food technology to crosslink proteins to improve their
functional properties. In a murine model, enzymatically
crosslinked beta-lactoglobulin  (CL-BLG) from milk
showed increased immunogenicity as well as sensitizing
capacity after oral application, by inducing the highest
IgE and IgG1 levels in serum and IL-13 in re-stimulated
T-cells; in contrast, lower levels of mMCP-1 as a marker
of mast cell degranulation were found after oral challenge
with crosslinked BLG [46]. Hence, a stronger allergic
sensitization but a lower anaphylactic response was eli-
cited by the dimer than by the monomer. Similarly, we
observed that BLG and alpha-lactalbumin after heat
treatment or pasteurization, respectively, exhibited dis-
tinct immune modulatory potency depending on the
aggregation state [49].
When the native allergens Bet v 1a, Bet v 1d, Bet v 2,
Phl p 6, Alt a 1, Hev b 8, Mal d 1, Api g 1 or Bos d
5 were investigated by native mass spectrometry, it
could be confirmed that they existed as transient
dimers, trimers or tetramers in solution [41]. Interest-
ingly, the hypoallergenic variant Bet v 1d was mainly
present as monomer.Current Opinion in Immunology 2016, 42:113–118 The concentration of proteins plays an important role in
the formation of homo-multimers, as co-localization in
cells may lead to a local increase of the protein concen-
tration up to 1 mM [50]. Further, in the case of non-
covalent dimerization, the size of the interface area be-
tween two monomers seems to determine the formation
and stability of the resulting dimer [51], where with
interfaces below 450 A˚ the allergen tends to remain
monomeric. But exceptions are possible, for example
Mus m 1 from mouse with a 389 A˚ interface diameter
is dimeric, and so is Per a 4 from cockroach at just 403 A˚.
However, dimers with an interface diameter around
1000 A˚ are assumed to be rather stable. Thus, for estima-
tion of the allergenic potential of a protein, the concen-
tration and the oligomerization state have to be taken into
consideration.
The concentration and aggregation state of proteins in
allergenic plants is substantially affected by environmen-
tal pollution. It is known that this is partly due to
enhanced protein expression as a plant defense mecha-
nism [52]. Further, nitration of proteins changes the
protein aggregation state and can led to enhanced allergic
responses in mouse models [53].
Taken together, the evidence is increasing that the
number and spacing of IgE epitopes, and especially
the display of repetitive epitopes, determines the induc-
tion and outcome of allergic reactions. This also supports
the concept of allergen-associated molecular patterns
(AAMPs).
Conclusion
Immediate-type allergy has two important biological
requirements: (1) formation of IgE antibodies to a specific
allergen by B-cells, and (2) crosslinking of FceRI-bound
specific IgE antibodies by allergen epitopes. The produc-
tion of antibodies by B-cells is most efficiently induced by
extensive crosslinking of the BCR by rigidly spaced
identical epitopes. The IgE antibody production may
then take place in a T-cell dependent or T-cell indepen-
dent manner, but in both cases critically depends on the
crosslinking event per se.
The IgE crosslinking capacity of the allergen is also
indispensable for stimulation of effector cells. In this
scenario, repetitive epitope display facilitates crosslinking
of the oligoclonal, but high-affinity IgE in allergic individ-
uals. In accordance with this, an impressive number of
important allergens has been identified as dimers and
oligomers, which prompt the formation of molecular pat-
terns of epitopes in close proximity. The epitopes can be
displayed (i) by single allergens in a repetitive manner, or
(ii) via homo-oligomerization through molecular forces, or
environmental or technical aggregation, and (iii) the oli-
gomers may occur permanently or transiently, but still be
biologically relevant. The accumulated evidence suggestswww.sciencedirect.com
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occur on molecules that are relevant as allergens, and that
they are decisive in the sensitization as well as in the
effector phase of type I allergy.
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